NeuroHawk
Pre-clinical- Indications
- Traumatic brain injury, Brain hemorrhage
Company intelligence / Profile preview
Sense Neuro Diagnostics has developed non-invasive headset devices for rapid detection and continuous monitoring of stroke subtypes and traumatic brain injuries. Their NeuSTAT™ and NeuroHawk devices have demonstrated the ability to detect intracerebral hemorrhage expansion earlier than standard care in clinical trials. The company has secured a $2 million contract to advance its technology for both military and civilian use. FDA clearance filing was planned for Q1 of 2025 with commercial launch targeted for mid–2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sense Neuro Diagnostics.